Correlation Between Cardio Diagnostics and Anebulo Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Anebulo Pharmaceuticals.

Diversification Opportunities for Cardio Diagnostics and Anebulo Pharmaceuticals

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Cardio and Anebulo is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Anebulo Pharmaceuticals

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 2.21 times more return on investment than Anebulo Pharmaceuticals. However, Cardio Diagnostics is 2.21 times more volatile than Anebulo Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  167.00  in Cardio Diagnostics Holdings on August 30, 2024 and sell it today you would lose (137.00) from holding Cardio Diagnostics Holdings or give up 82.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Anebulo Pharmaceuticals

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cardio Diagnostics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Cardio Diagnostics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cardio Diagnostics and Anebulo Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Anebulo Pharmaceuticals

The main advantage of trading using opposite Cardio Diagnostics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.
The idea behind Cardio Diagnostics Holdings and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios